Brexit

Sanofi ready for a Brexit 'no deal' scenario

18 th February 2019

Sanofi, explains how the company will manage the access to the vaccines and medicines they produce after Brexit.

In a  LinkedIn post, Hugo Fry, Managing Director UK of Sanofi, explains how the company will organise to manage the access to the vaccines and medicines they produce after Brexit.

 

 

More news